Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2007

01-04-2007

Outcome and Prognostic Factors in Patients with Hematologic Malignancies Admitted to the Intensive Care Unit: A Single-Center Experience

Authors: Christelle Ferrà, Pilar Marcos, Maite Misis, Mireia Morgades, María-Luisa Bordejé, Albert Oriol, Natalia Lloveras, Juan-Manuel Sancho, Blanca Xicoy, Montserrat Batlle, Jordi Klamburg, Evarist Feliu, Josep-Maria Ribera

Published in: International Journal of Hematology | Issue 3/2007

Login to get access
Metadata
Title
Outcome and Prognostic Factors in Patients with Hematologic Malignancies Admitted to the Intensive Care Unit: A Single-Center Experience
Authors
Christelle Ferrà
Pilar Marcos
Maite Misis
Mireia Morgades
María-Luisa Bordejé
Albert Oriol
Natalia Lloveras
Juan-Manuel Sancho
Blanca Xicoy
Montserrat Batlle
Jordi Klamburg
Evarist Feliu
Josep-Maria Ribera
Publication date
01-04-2007
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2007
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.E0625

Other articles of this Issue 3/2007

International Journal of Hematology 3/2007 Go to the issue

Letter to the Editor

Trisomy 21 as the Sole Acquired Karyotypic Abnormality in Biphenotypic Acute Leukemia

OriginalPaper

Peroxisome Proliferator-Activated Receptor γ and Retinoic Acid Receptor Synergistically Up-Regulate the Tumor Suppressor PTEN in Human Promyeloid Leukemia Cells

Images in Hematology

Acute Myeloid Leukemia—Cuplike: Characteristic Peroxidase Staining Pattern

Case Report

Epstein-Barr Virus-Positive Blastoid Variant of Mantle Cell Lymphoma in an Adult with Recurrent Infectious Mononucleosis-Like Symptoms: A Case Report

Case Report

Reversible Cardiomyopathy Associated with Multicentric Castleman Disease: Successful Treatment with Tocilizumab, an Anti—Interleukin 6 Receptor Antibody

Letter to the Editor

Epstein-Barr Virus Infection after Unrelated Cord Blood Transplantation: Reactivation or Reinfection?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits